Company Filing History:
Years Active: 2002-2009
Title: Michael Weidner: Innovator in Cancer Treatment
Introduction
Michael Weidner is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of medical science, particularly in cancer treatment. With a total of 12 patents to his name, Weidner's work focuses on innovative solutions for combating diseases.
Latest Patents
Among his latest patents, Weidner has developed mono-acylated o-phenylendiamines derivatives. These derivatives are particularly useful for the treatment of diseases mediated by the inhibition of histone deacetylase, such as cancer. Additionally, he has invented methods for detecting cancer cells by using nucleic acid encoding for IGF-1 receptor interacting proteins. This method specifically relates to the detection of tumor cell proliferation, utilizing nucleic acids that encode IIP-1.
Career Highlights
Michael Weidner is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to focus on groundbreaking research and development in cancer therapies.
Collaborations
Weidner has collaborated with several talented individuals in his field, including Anja Limberg and Georg Fertig. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Michael Weidner's contributions to cancer treatment through his innovative patents highlight his dedication to improving medical science. His work continues to pave the way for advancements in the detection and treatment of cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.